Sign in
Taking people in United StatesNo phase

Magnetic brain stimulation for depression after spinal cord injury

Tests rTMS brain stimulation for depression in adults with spinal cord injury.

Key facts

Who runs it
Medical University of South Carolina
Where
Charleston, United StatesSee the site
Trial code
Registry title
Treatment of Depression Post-SCI
Status
Recruiting
People taking part
14 people, planned
Starts
May 2027
Expected to end
Sept 2029
Type of study
Interventional
Treatments tested
  • rTMS
Record updated
17 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a spinal cord injury in the neck or upper back and major depression. It tests rTMS, a brain stimulation done from outside the head.

Age
18 to 70 years
Sex
All sexes
Disease stage
At least 6 months after an incomplete cervical (neck) injury, or an incomplete or complete thoracic (upper back) injury. Major depressive disorder found by screening tools. At least some active movement of the right thumb.
Earlier treatment
No antidepressant medicines, or no change in doses of mental health medicines for at least 4 weeks before the study (6 weeks if the medicine was newly started).

Main reasons for not taking part

  • Other nervous system diseases, dementia, memory or thinking problems, or past major head injury
  • Past psychosis, bipolar disorder, or a suicide attempt in the last 2 years
  • Metal or electronic implants, such as a pacemaker or cochlear implant
  • Past seizures, or taking anti-seizure medicines or medicines that raise seizure risk
  • Pregnancy, or life expectancy under 1 year

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Age 18 - 70
  • At least 6 months post incomplete cervical or incomplete or complete thoracic level SCI
  • Have at least partial active movement of the right thumb (abductor pollicis brevis) to allow for FDA approved rTMS dosing
  • Major depressive disorder, as identified through screening tools
  • No antidepressant medications or no change in doses of psychotropic medication(s) for at least 4 weeks prior to the study (6 weeks if newly initiated medication)

Who cannot take part

  • Concomitant neurologic diseases/disorders or dementia
  • Electronic or metallic implants (i.e. metal in the head, cochlear implant, or pacemaker)
  • Cognitive impairment, as identified through a screening tool (Montreal Cognitive Assessment)
  • History of major head trauma as identified through a screening tool (Ohio State University Traumatic Brain Injury Identification Method)
  • History of psychosis or other Axis I disorder that is primary
  • Positive screen for bipolar disorder, as identified through a screening tool (The Mood Disorder Questionnaire)
  • History of seizures or currently prescribed anti-seizure medications
  • Taking medication that increases the risk of seizures
  • Life expectancy <1 year
  • Attempt of suicide in the last 2 years
  • Pregnancy as identified through a positive pregnancy test
  • Inability or unwillingness of subject or legal guardian/representative to give informed consent

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

This trial is currently available in United States.

  • Medical University of South CarolinaCharleston, United StatesContact: Catherine VanDerwerker, DPT, PhDTaking people

About the trial

What the trial wants to find out

Depression is more common after a spinal cord injury (SCI) than in the general population. Unfortunately, it is unknown how depression is typically treated in individuals with SCI or if commonly used treatment methods are effective. This study will investigate the safety and impact of a novel method for treating depression called repetitive transcranial magnetic stimulation (rTMS). rTMS is a type of non-invasive brain stimulation. Fourteen individuals with a cervical or thoracic level SCI and depression will complete an approved treatment plan using rTMS. Participants will be treated using rTMS five days a week for four weeks. After four weeks of treatment, the study team will review the safety of rTMS and assess changes in depressive symptoms. If the results are positive, larger studies can be designed to develop better treatment options for individuals with SCI and depression.

The group in the trial

  • rTMS (Repetitive Transcranial Magnetic Stimulation)Treatment being tested

    Treatment: rTMS

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Treatment of Depression Post-SCI: Retrospective Analysis and Feasibility Trial
Plain-language title
Magnetic brain stimulation for depression after spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT04263285, who can take part
Record updated
17 November 2026